Side-by-side comparison of AI visibility scores, market position, and capabilities
Finch Therapeutics develops microbiome-based medicines targeting the gut-brain and gut-immune axis with programs in autism spectrum disorder and C. difficile.
Finch Therapeutics is a clinical-stage biotechnology company founded in 2015 that develops microbiome medicines targeting the relationship between the gut microbiome and systemic diseases. The company is focused on two primary therapeutic areas: gastrointestinal infections including C. difficile and conditions involving the gut-brain axis including autism spectrum disorder where gut microbiome alterations have been associated with symptom severity. Finch's lead microbiome program CP101 targets recurrent C. difficile infection, competing in the same emerging microbiome therapeutics space as Seres Therapeutics. The company also conducts research on the COMET platform for autism spectrum disorder, exploring whether microbiome restoration can improve behavioral symptoms through the gut-brain connection. Finch has raised over $165M and has conducted multiple clinical trials of its microbiome medicines. The company's autism program represents a particularly innovative and scientifically ambitious program given the emerging evidence that gut microbiome composition influences neurological development and behavior. Finch's work contributes to the broader scientific validation of microbiome medicine as a legitimate therapeutic class beyond C. difficile.
Llama 4 open-source model (Scout, Maverick, Behemoth) released March 2026; Meta AI assistant deployed to 700M+ users across WhatsApp, Instagram, Facebook. FAIR research driving multimodal AI advances; $35B AI capex in 2025.
Meta Platforms is a Menlo Park, California-based technology conglomerate operating the world's most widely used social media ecosystem — Facebook (3+ billion monthly active users), Instagram (2+ billion MAU), WhatsApp (2.8+ billion MAU), and Threads (launched 2023) — while investing heavily in virtual reality hardware (Meta Quest), augmented reality glasses (Meta Ray-Ban, Orion AR glasses in development), and AI research (Llama open-source model family). Listed on NASDAQ (NASDAQ: META), Meta generated $164.5 billion in revenue in fiscal year 2024 and employs approximately 74,000 people globally.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.